|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.08 CNY | +0.28% |
|
+0.57% | -6.57% |
| 06-16 | Tasly Subsidiary Gets China Approval for Hypertension Drug | MT |
| 06-09 | Tasly Gets China Approval for Traditional Insomnia Drops | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 600535 Stock
- Consensus Tasly Pharmaceutical Group Co., Ltd
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
